Antitumor Research of the Active Ingredients from Traditional Chinese Medical Plant Polygonum Cuspidatum

被引:26
|
作者
Wu, Xinnan
Li, Qi
Feng, Yu [1 ]
Ji, Qing [1 ]
机构
[1] Shanghai Univ Tradit Chinese Med, Shuguang Hosp, Dept Med Oncol, Shanghai 201203, Peoples R China
基金
中国国家自然科学基金;
关键词
EPITHELIAL-MESENCHYMAL TRANSITION; HUMAN BREAST-CANCER; LUNG-CANCER; CELL-CYCLE; OXIDATIVE STRESS; RESVERATROL; APOPTOSIS; INFLAMMATION; INHIBITION; KINASE;
D O I
10.1155/2018/2313021
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
In recent years, the utilization of Chinese native medicine and other plant extracts in the treatment of diseases has attracted extensive attention, especially in the area of malignant tumors. However, lots of herbal remedies active ingredients have not been found or have been discovered but not effectively developed and applied. Therefore, screening new Chinese medicine active components and determining their antitumor effects have become a new breakthrough in the prevention and treatment of tumor disease. In the past years, a large number of studies have demonstrated that Polygonum cuspidatum and its active components like resveratrol showed excellent antitumor activities, including our own antitumor studies about resveratrol in colorectal cancer. The purpose of this review is to summarize the research progress of Chinese herb Polygonum cuspidatum and its active components in tumor diseases and provide theoretical basis for further scientific experiments and clinical applications.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] Molecular targeted study in tumors: From western medicine to active ingredients of traditional Chinese medicine
    Li, Ruixiao
    Li, Qi
    Ji, Qing
    BIOMEDICINE & PHARMACOTHERAPY, 2020, 121
  • [32] Targeting immunometabolism by active ingredients derived from traditional Chinese medicines for treatment of rheumatoid arthritis
    He, Yu-fei
    Mai, Chu-tian
    Pan, Hu-dan
    Liu, Liang
    Zhou, Hua
    Xie, Ying
    CHINESE HERBAL MEDICINES, 2021, 13 (04) : 451 - 460
  • [33] Research Progress of Plant Active Ingredients in Pharmaceutical Cocrystal
    Wang, Zimeng
    Shang, Hongzhou
    Gao, Linghuan
    Qiao, Ning
    CURRENT DRUG DELIVERY, 2023, 20 (10) : 1405 - 1424
  • [34] Effects of active ingredients from traditional Chinese medicines on glycogen molecular structure in diabetic mice
    Li, Cheng
    Gan, Hua
    Tan, Xinle
    Hu, Zhenxia
    Deng, Bin
    Sullivan, Mitchell A.
    Gilbert, Robert G.
    EUROPEAN POLYMER JOURNAL, 2019, 112 : 67 - 72
  • [35] Targeting immunometabolism by active ingredients derived from traditional Chinese medicines for treatment of rheumatoid arthritis
    Yu-fei He
    Chu-tian Mai
    Hu-dan Pan
    Liang Liu
    Hua Zhou
    Ying Xie
    Chinese Herbal Medicines, 2021, 13 (04) : 451 - 460
  • [36] Targeting immunometabolism by active ingredients derived from traditional Chinese medicines for treatment of rheumatoid arthritis
    Yu-fei He
    Chu-tian Mai
    Hu-dan Pan
    Liang Liu
    Hua Zhou
    Ying Xie
    Chinese Herbal Medicines, 2021, (04) : 451 - 460
  • [37] Antifungal and Immunomodulatory Ingredients from Traditional Chinese Medicine
    Zhong, Hua
    Han, Lei
    Lu, Ren-Yi
    Wang, Yan
    ANTIBIOTICS-BASEL, 2023, 12 (01):
  • [38] Research Progress on Structural Modification of Effective Antitumor Active Ingredients in Licorice
    Liu, Chi
    Ma, Qing
    Gong, Guangfei
    Su, Fengyan
    MOLECULES, 2023, 28 (15):
  • [39] A Computational Toxicology Approach to Screen the Hepatotoxic Ingredients in Traditional Chinese Medicines: Polygonum multiflorum Thunb as a Case Study
    He, Shuaibing
    Zhang, Xuelian
    Lu, Shan
    Zhu, Ting
    Sun, Guibo
    Sun, Xiaobo
    BIOMOLECULES, 2019, 9 (10)
  • [40] Nano-formulated delivery of active ingredients from traditional Chinese herbal medicines for cancer immunotherapy
    Shang, Qi
    Liu, Wandong
    Leslie, Faith
    Yang, Jiapei
    Guo, Mingmei
    Sun, Mingjiao
    Zhang, Guangji
    Zhang, Qiang
    Wang, Feihu
    ACTA PHARMACEUTICA SINICA B, 2024, 14 (04) : 1525 - 1541